These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4710371)

  • 1. Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.
    Lewis RJ; Trager WF; Robinson AJ; Chan KK
    J Lab Clin Med; 1973 Jun; 81(6):925-31. PubMed ID: 4710371
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.
    Hewick DS; McEwen J
    J Pharm Pharmacol; 1973 Jun; 25(6):458-65. PubMed ID: 4146584
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin metabolism in man: identification of metabolites in urine.
    Lewis RJ; Trager WF
    J Clin Invest; 1970 May; 49(5):907-13. PubMed ID: 5441544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.
    Yacobi A; Wingard LB; Levy G
    J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a method for the analysis of warfarin and metabolites in plasma and urine.
    de Vries JX; Schmitz-Kummer E
    Am Clin Lab; 1995 Jul; 14(7):20-1. PubMed ID: 10155056
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second reported kindred with hereditary resistance to oral anticoagulant drugs.
    O'Reilly RA
    N Engl J Med; 1970 Jun; 282(26):1448-51. PubMed ID: 4192578
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between the kinetics of the anticoagulant effects of racemic warfarin and its individual enantiomers in man.
    Levy G; O'Reilly RA; Wingard LB
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):359-65. PubMed ID: 4594366
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin therapy. 2.
    Deykin D
    N Engl J Med; 1970 Oct; 283(15):801-3. PubMed ID: 4917271
    [No Abstract]   [Full Text] [Related]  

  • 13. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin K and the oral anticoagulant drugs.
    O'Reilly RA
    Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin revisited.
    Deykin D
    N Engl J Med; 1970 Jun; 282(26):1486. PubMed ID: 5419298
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heparins and antivitamins K].
    Langer B
    Rev Paul Med; 1990; 108(4):183-8. PubMed ID: 2095622
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute configurations of the four warfarin alcohols.
    Chan KK; Lewis RJ; Trager WF
    J Med Chem; 1972 Dec; 15(12):1265-70. PubMed ID: 4635971
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulant drugs: pharmacokinetic aspects.
    Breckenridge A
    Semin Hematol; 1978 Jan; 15(1):19-26. PubMed ID: 341326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.